Home / Resources / Videos / ADA 2018 / Catherine Champagne Part 7, Fad Drinks And Drink Substitutes

Catherine Champagne Part 7, Fad Drinks And Drink Substitutes




In part 7, the conclusion of this Exclusive Interview, Catherine Champagne talks with Diabetes in Control Publisher Steve Freed about the science behind some popular drinks.

Catherine M. Champagne, PhD, RDN, LDN, FADA, FAND, FTOS  is a professor at the Pennington Biomedical Research Center at Louisiana State University.

 

Transcript of this video segment:

Freed: What about coconut water. We see so many new things in the grocery stores; now they have all these different coconut waters. I keep looking but I’m not sure if it’s healthy.

Champagne: I haven’t seen a lot of data on coconut water. But to me, why would you pay for something that you don’t know whether it has any science behind it to support the fact that is good, it’s any better for your body than just regular water?

Freed: It’s a lot less expensive for regular water.

Champagne: Regular water is pretty cheap. You know it may be, I find that there are some people that that really migrate towards something that’s an imitation. Not really in technical terms, but sort of mimics, you know, water. So there’s a lot of hype about coconut water. There’s also a lot of interest in milk substitutes for regular dairy milk. So a lot of people are lactose intolerant and they may have a reason to go towards either almond milk or other nut milks. But in terms of looking at the comparison between regular milk and these other options like Silk or any of the other brands that are available, I find it more of a challenge to find the amount of protein in those nut milks as opposed to the amount of protein that you get in milk. There are one or two that are higher in protein but you really have to do a lot of searching, whereas you can have some confidence that the dairy milk, if you are not lactose intolerant, is the better choice and cheaper.

Freed: That’s really — all facts are based on science. Sometimes these companies have a patient database of four and they come out and they don’t say it’s four people; they say we did a study and it shows that it reduces our risk by 80 percent. Which really is an invalid study.

Champagne: And actually that brings up a good point. You know that’s anecdotal evidence. That’s not a scientifically rigorously controlled study. So you really have to look for the science.

 

Return to the main page.